Año 2020 / Volumen 112 / Número 6
Original
The relationship between integrin avß6 and HBV infection in patients with liver cirrhosis and hepatocellular carcinoma: a preliminary report

462-466

DOI: 10.17235/reed.2020.6607/2019

Zhao-Bin He, Wei-Bo Niu, Cheng Peng, Chao Gao, Hui-Jie Gao, Jun Niu,

Resumen
Objective: the aim of this study was to investigate the expression of integrin αvβ6 in normal, hepatitis B, HBV-associated cirrhosis and HBV-associated HCC liver tissues. Methods: immunohistochemistry and real-time quantitative reverse transcription polymerase chain reaction (RT-qPCR) were used to study the expression of integrin αvβ6 in HBV-associated cirrhosis (n = 88), chronic hepatitis B ( n= 11), HBV-associated HCC (n = 84) and normal (n = 10) human liver tissues. Results: the expression of integrin αvβ6 was significantly upregulated in HBV-associated liver cirrhosis and the expression increased with an increase in severity of cirrhosis. Furthermore, it was moderately or weakly expressed in chronic hepatitis B and HBV-associated HCC liver tissues when compared to normal liver tissue. Conclusion: integrin αvβ6 could be a predictive marker for the progression of liver cirrhosis associated with HBV infection. Further studies are needed to determine the association between the expression of integrin αvβ6 in hepatitis B and HBV-associated HCC liver tissues.
Share Button
Nuevo comentario
Comentarios
No hay comentarios para este artículo.
Bibliografía
1. Sarin SK, Kumar M, Lau GK, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int 2016;10:1-98.
2. Liaw YF. Antiviral therapy of chronic hepatitis B: opportunities and challenges in Asia. J Hepatol 2009;51:403-410.
3. Bertoletti A, Le Bert N. Immunotherapy for Chronic Hepatitis B Virus Infection. Gut Liver 2018;12:497-507.
4. Bosch FX, Ribes J, Cléries R, et al. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2005;9:191-211.
5. Balogh J, Victor D 3rd, Asham EH, et al. Hepatocellular carcinoma: a review. J Hepatocell Carcinoma 2016;3:41-53.
6. van Bömmel F, Berg T. Treatment of HBV related cirrhosis. Liver Int 2013;33 Suppl 1:176-181.
7. Ghany MG, Doo EC. Antiviral resistance and hepatitis B therapy. Hepatology 2009;49:S174-184.
8. Lemyze M, Dharancy S, Wallaert B. Response to exercise in patients with liver cirrhosis: implications for liver transplantation. Dig Liver Dis 2013;45:362-366.
9. Said A, Lucey MR. Liver transplantation: an update 2008. Curr Opin Gastroenterol 2008;24:339-345.
10. Zhou WC, Zhang QB, Qiao L. Pathogenesis of liver cirrhosis. World J Gastroenterol 2014;20:7312-7324.
11. Cohen-Naftaly M, Friedman SL. Current status of novel antifibrotic therapies in patients with chronic liver disease. Therap Adv Gastroenterol 2011;4:391-417.
12. Ramachandran P, Henderson NC. Antifibrotics in chronic liver disease: tractable targets and translational challenges. Lancet Gastroenterol Hepatol 2016;1:328-340.
13. Hynes RO. Integrins: bidirectional, Allosteric signaling machines. Cell 2002;110:673-687.
14. Breuss JM, Gallo J, DeLisser HM, et al. Expression of the beta 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling. J Cell Sci 1995;108:2241-2251.
15. Munger JS, Huang X, Kawakatsu H, et al. The integrin αvβ6 binds and activates latent TGF-β1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 1999;96:319-328.
16. Hahm K, Lukashev ME, Luo Y, et al. αvβ6 Integrin regulates renal fibrosis and inflammation in the Alport mouse. Am J Pathol 2007;170:110-125.
17. Wang B, Dolinski BM, Kikuchi N, et al. Role of alphavbeta6 integrin in acute biliary fibrosis. Hepatology 2007;46:1404-1412.
18. Popov Y, Patsenker E, Stickel F, et al. Integrin αvβ6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies. J Hepatol 2008;48:453-464.
19. Batts KP, Ludwig J. Chronic hepatitis: an update on terminology and reporting. Am J Surg Pathol 1995;19:1409-1417.
20. Horan GS, Wood S, Ona V, et al. Partial inhibition of integrin α (v) β6 prevents pulmonary fibrosis without exacerbating inflammation. Am J Respir Crit Care Med 2008;177:56-65.
21. Patsenker E, Popov Y, Stickel F, et al. Inhibition of integrin αvβ6 on cholangiocytes blocks transforming growth factor-β activation and retards biliary fibrosis progression. Gastroenterology 2008;135:660-670.
22. Moutasim KA, Jenei V, Sapienza K, et al. Betel-derived alkaloid up-regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis. J Pathol 2011;223:366-377.
23. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001;344:495-500.
24. Procopet B, Berzigotti A. Diagnosis of cirrhosis and portal hypertension: imaging, non-invasive markers of fibrosis and liver biopsy. Gastroenterol Rep (Oxf) 2017;5:79-89.
25. Cho EJ, Kim MY, Lee JH, et al. Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease. PLoS One 2015;10:e0133935.
26. Zarski JP, Sturm N, Guechot J, et al; ANRS HCEP 23 Fibrostar Group. Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study. J Hepatol 2012;56:55-62.
27. Yoon YJ, Friedman SL, Lee YA. Antifibrotic Therapies: Where Are We Now? Semin Liver Dis 2016;36:87-98.
Artículos relacionados

Editorial

Hemofilia y hepatología, un regreso al futuro

DOI: 10.17235/reed.2024.10105/2023

Carta

Reactivación del virus de la hepatitis B por ibrutinib

DOI: 10.17235/reed.2023.9587/2023

Editorial

New actors come into play against hepatitis delta

DOI: 10.17235/reed.2022.9050/2022

Imagen en Patología Digestiva

Hepatocarcinoma quístico gigante en ausencia de cirrosis

DOI: 10.17235/reed.2021.8313/2021

Carta

Biopsia en el carcinoma hepatocelular: solo en ocasiones

DOI: 10.17235/reed.2020.6935/2020

Carta

Diagnóstico de hepatocarcinoma. Una reflexión necesaria

DOI: 10.17235/reed.2020.6845/2019

Carta

Rabdomiolisis en paciente en tratamiento con sorafenib

DOI: 10.17235/reed.2020.6440/2019

Caso Clínico

Hepatocarcinoma sobre hígado ectópico peritoneal

DOI: 10.17235/reed.2019.6408/2019

Imagen en Patología Digestiva

Debut de cirrosis hepática poco habitual

Instrucciones para citar
He Z, Niu W, Peng C, Gao C, Gao H, Niu J, et all. The relationship between integrin avß6 and HBV infection in patients with liver cirrhosis and hepatocellular carcinoma: a preliminary report. 6607/2019


Descargar en un gestor de citas

Descargue la cita de este artículo haciendo clic en uno de los siguientes gestores de citas:

Métrica
Este artículo ha sido visitado 836 veces.
Este artículo ha sido descargado 137 veces.

Estadísticas de Dimensions


Estadísticas de Plum Analytics

Ficha Técnica

Recibido: 03/09/2019

Aceptado: 13/12/2019

Prepublicado: 26/05/2020

Publicado: 08/06/2020

Tiempo de revisión del artículo: 90 días

Tiempo de prepublicación: 266 días

Tiempo de edición del artículo: 279 días


Compartir
Este artículo aun no tiene valoraciones.
Valoración del lector:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
La REED es el órgano oficial de la Sociedad Española de Patología Digestiva, la SociedadEspañola de Endoscopia Digestiva y la Asociación Española de Ecografía Digestiva
Política de cookies Política de Privacidad Aviso Legal © Copyright 2023 y Creative Commons. Revista Española de Enfermedades Digestivas